Ƶ

Elephants and Alzheimer's; Omega-3 and Epilepsy; Eye Disease and Dementia

— News and commentary from the world of neurology and neuroscience

Ƶ MedicalToday

Elephants never forget, the saying goes. disease? (Fortune)

Whether is beneficial, neutral, or harmful for ) is unclear, neurologists argue. (JAMA Neurology)

may be tied to increased Alzheimer's disease risk, a study of 3,800 patients reported. (Alzheimer's and Dementia)

The FDA approved the first RNA interference drug, patisiran (Onpattro), to treat polyneuropathy associated with hereditary transthyretin amyloidosis.

After scrapping its in-house neuroscience work earlier this year, startups. (Endpoints News)

A daily pack of increased the relapse rate of relapsing-remitting multiple sclerosis by 38%, Danish researchers reported. (Multiple Sclerosis Journal)

A with a friendly face may be able to teach social skills to children with autism. (IEEE Spectrum)

Innate Immunotherapeutics, an Australian biotech company that was testing the , is at the center of the Rep. Christopher Collins (R-N.Y.) insider trading story. (New York Times)

More than half the even though planning for pregnancy is of "utmost importance" for these patients, researchers said. (Neurology)

PARP (poly-ADP ribose polymerase) inhibitors, a targeted therapy for certain types of cancer, show promise in treating , Penn researchers reported. (Fierce Biotech)